Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

Cash in on Apple's Smash-Hit iPhone 6 – Without Buying a Single Share

Shares of Apple Inc. (Nasdaq: AAPL) cracked the $100-a-share threshold this week and set a new all-time record of $101.09 as investors have suddenly realized the iDevice king is gearing up for a monster grand finale to 2014.

You’re not surprised, of course. Apple shares have gained nearly 70% since Capital Wave Forecast Editor Shah Gilani recommended the stock to you on July 10, 2013. And they’ve zoomed nearly 26% since Shah re-recommended the shares at the very end of last year… Full Story

  • This Alzheimer's "Pacemaker" Could Be the Bridge to a Cure There's good news for Alzheimer's patients after all...

    This news comes at an opportune time. Just last summer, the whole effort suffered a major setback.

    That's when three Big Pharma firms said they were halting development of Alzheimer's compounds because the medicines simply didn't work. No doubt, that was a blow for both patients and investors in Eli Lilly & Co. (NYSE:LLY), Pfizer Inc. (NYSE:PFE), and Johnson & Johnson (NYSE:JNJ).

    But this month we learned that a research team at Johns Hopkins has for the first time implanted a promising device into the brain of a U.S. Alzheimer's patient. It seems to combat the effects of Alzheimer's by providing deep-brain stimulation. It works very much like the pacemaker that's normally used in the heart.

    Over the next year or so, a total of 40 patients will receive the implants under a federally funded trial.

    This is a big move with very promising potential. You see, doctors have used a similar device to control Parkinson's disease for about the past 15 years, with some 80,000 patients receiving the implants. They report having fewer seizures and needing less medication.

    I believe this very well could be the bridge technology we need until a true "cure" for Alzheimer's is found. Right now, the chances look good that this interim step will succeed.

    "This is a very different approach, whereby we are trying to enhance the function of the brain mechanically," says Dr. Paul B. Rosenberg. "It's a whole new avenue for potential treatment for a disease becoming all the more common with the aging of the population."

    As high-tech investors, we need to keep an eye on this research and be ready to pounce when a medical-device maker gets it to market.

    I don't know just when that will happen. But when it does, you can bet that I'll drop you a line.

    Meantime, I have four more fascinating developments to share with you today.

    Take a look...

    To continue reading, please click here... Read More...